- Report
- May 2024
- 129 Pages
Global
From €3500EUR$3,999USD£3,042GBP
- Report
- May 2024
- 128 Pages
Global
From €3500EUR$3,999USD£3,042GBP
- Report
- May 2024
- 135 Pages
Global
From €3500EUR$3,999USD£3,042GBP
- Report
- May 2023
- 118 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- August 2022
- 115 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- May 2024
- 70 Pages
United States
From €3457EUR$3,950USD£3,005GBP
- Report
- July 2024
- 175 Pages
Global
From €2188EUR$2,500USD£1,902GBP
- Report
- January 2024
- 200 Pages
Global
From €3632EUR$4,150USD£3,157GBP
- Report
- January 2025
- 175 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- June 2024
- 200 Pages
Global
From €6958EUR$7,950USD£6,048GBP
- Report
- November 2023
- 630 Pages
Global
From €8314EUR$9,500USD£7,227GBP
- Report
- September 2024
- 82 Pages
Japan
From €3063EUR$3,500USD£2,663GBP
- Report
- August 2024
- 80 Pages
Japan
From €3063EUR$3,500USD£2,663GBP
- Report
- October 2023
- 183 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- January 2025
- 175 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- January 2025
- 175 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- January 2025
- 175 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- January 2025
- 175 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- April 2023
- 120 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- May 2024
- 138 Pages
Global
From €3500EUR$3,999USD£3,042GBP

Lymphoma is a type of hematological malignancy that originates in the lymphatic system. It is characterized by the uncontrolled growth of lymphocytes, a type of white blood cell. Lymphomas can be either Hodgkin's or non-Hodgkin's, and can be either indolent or aggressive. Treatment options for lymphoma include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies.
The lymphoma market is a subset of the larger hematology market, which includes treatments for a variety of blood-related diseases. The lymphoma market is driven by the increasing prevalence of the disease, as well as the development of new treatments.
Companies in the lymphoma market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Gilead Sciences, Novartis, and Pfizer. Show Less Read more